A 6-gene signature identifies four molecular subgroups of neuroblastoma

Frida Abel, Daniel Dalevi, Maria Nethander, Rebecka Jörnsten, Katleen De Preter, Joëlle Vermeulen, Raymond Stallings, Per Kogner, John M. Maris, Staffan NilssonCancer 2011 · DOI

Abstract

Based on expression profiling we have identified four molecular subgroups of neuroblastoma, which can be distinguished by a 6-gene signature. The fourth subgroup has not been described elsewhere, and efforts are currently made to further investigate this group's specific characteristics.

Introduction

Neuroblastoma (NB) is a highly heterogeneous childhood cancer. Traditionally, it has been categorized into three genomic subtypes: Type 1 (low-risk), Type 2A (intermediate-risk), and Type 2B (high-risk, MYCN-amplified). However, these classifications often fail to predict the clinical course for intermediate cases. This study utilizes unsupervised gene expression profiling to refine these categories and identify a previously overlooked high-risk subgroup.

Methods and Data

The researchers analyzed three independent microarray datasets (De Preter et al., McArdle/Wilzén et al., and Wang et al.) using Principal Components Analysis (PCA) and hierarchical clustering. To simplify the molecular classification, they distilled a broad set of genes into a robust 6-gene signature consisting of ALK, BIRC5, CCND1, MYCN, NTRK1, and PHOX2B.

PCA analysis of neuroblastoma datasets showing four distinct clusters (p1-p4) and the expression patterns of the 6-gene signature.

Identification of a Novel Subgroup

The most striking finding was the consistent identification of a fourth cluster (p4) across all datasets. This group primarily consists of tumors that lack MYCN amplification (MNA-negative) but often harbor 11q deletions. Despite lacking the traditional MYCN high-risk marker, the p4 group exhibited poor overall survival (~50.5% in the validation set), comparable to the MYCN-amplified p3 group.

Distribution of molecular markers across the four identified subgroups (p1-p4).

The 6-Gene Signature

The 6-gene signature proved sufficient to statistically discriminate all four clusters (p < 0.05). Notably:

  • p1 (Type 1): Characterized by high NTRK1 expression and 100% survival.
  • p3 (Type 2B): Characterized by high MYCN, ALK, BIRC5, and PHOX2B.
  • p4 (Novel): Shows low expression of ALK, BIRC5, and PHOX2B, suggesting a different biological driver than the p3 group despite similar poor outcomes.

Conclusion

This study demonstrates that a minimalist 6-gene signature can effectively stratify neuroblastoma patients into four biologically distinct groups. The discovery of the p4 subgroup highlights a critical gap in current clinical risk assessment, identifying a high-risk population that requires further investigation for targeted therapies.

Summary updated

Abstract

Based on expression profiling we have identified four molecular subgroups of neuroblastoma, which can be distinguished by a 6-gene signature. The fourth subgroup has not been described elsewhere, and efforts are currently made to further investigate this group's specific characteristics.
BibTeX
@inproceedings{abel2011gene,
  author = {Frida Abel and Daniel Dalevi and Maria Nethander and Rebecka Jörnsten and Katleen De Preter and Joëlle Vermeulen and Raymond Stallings and Per Kogner and John M. Maris and Staffan Nilsson},
  title = {{A 6-gene signature identifies four molecular subgroups of neuroblastoma}},
  booktitle = {Cancer},
  year = {2011},
  doi = {10.1186/1475-2867-11-9},
}
Figure